Tibi gratias ago pro visitare nature.com. Et pasco versio vos es usura habet limited css firmamentum. Nam optimum experientia, nos suadeo ut vos utor an updated pasco (vel inactivare compatibility modus in Penitus Rimor). In interim, ut continua firmamentum, nos reddere locum sine styles et JavaScript.
Peptides et proteins late solebat tractare varietate morborum, sed plerumque habent infusum et eorum effectus brevis. Hi defectus de patria structurae potest eliminated cum auxilio Molecular ipsum, sed hoc est difficile negotium. Molecular Engineering artes, principio applicantur insulin nunc feliciter applicari plures Biopharmaceuticals requirere derivatization peptides et proteins ex pingue acida. Et propria ratio et locus ad attachiatus pingue acida potest providere diversis elongationem machinationes. Praeterea, hoc technology potest providere a diu dimidium-vita post oris administratione peptide medicinae, ut mutare distribution de peptides, et potest habere potential ad TEXTUS targeting. Cum inhaerens salutem adipem acida et bene defined eget proprietatibus, hoc technology praebet versatile aditus ad peptide et dapibus medicamento inventa.
Omnes prices sunt rete. Vat et addidit post in Checkout. Tributum calculations fiat in Checkout.
Muttenthaler, M., Rex, GF, Adams, DJ & Alewood, PF trends in peptide medicamento inventa. Muttenthaler, M., Rex, GF, Adams, DJ & Alewood, PF trends in peptide medicamento inventa.Muttenthaler, M. Rex, GF, Adams, DJ et ALevud, PF trends in peptide medicamento inventa. Muttenthaler, M. Rex, GF, Adams, DJ & Alewood, PF 多肽药物发现的趋势. Muttenthaler, M. Rex, GF, Adams, DJ & Alewood PFMuttenthaler, M. Rex, GF, Adams, DJ et ALevud, PF trends in peptide medicamento inventa.Nationalibus ostium de medicamento pastor. XX, 309-325 (MMXXI). Hoc recensionem focuses in current et futura facies peptide medicamento inventa.
Müller, TD, Blühher, M., Tschöp, MH & Dimarchi, Rd Anti-ADIPS medicamento Inventionis: Advances et challenges. Müller, TD, Blühher, M., Tschöp, MH & Dimarchi, Rd Anti-ADIPS medicamento Inventionis: Advances et challenges.Müller, TD, Blucher, M., dolor, MH et Dimarchi, RD Anti-ADIPS medicamento Inventionis: Progress et challenges. Müller, TD, Blüher, M., Tschöp, MH & Dimarchi, RD 抗肥胖药物发现: 进展和挑战. Müller, TD, Blüher, M., Tschöp, MH & Dimarchi, RDMüller, TD, Blucher, M., dolor, MH et Dimarchi, RD Anti-ADIPS medicamento Inventionis: Progress et challenges.Nationalibus ostium de medicamento pastor. XXI, 201-223 (MMXII). Hanc recensionem providet prudentia in quaestiones de ADIPS, praesertim novam conceptibus secundum peptides.
Strohl, WR fusion proteins ad extend ad dimidium-vita biologica ut optimus belli ad biologics. Biopharmaceutics XXIX, 215-239 (MMXV).
Evans, M. et al. Adhaesione et Perseverantia antidiabetic medicamentis et consociatio cum orci et oeconomica eventus in aegris cum type II diabetes: systematicam review de litterae. Diabetic ADIPS. metabolism. XXIV, 377-390 (MMXII).
Polonsky, Wh, Fisher, L., Hessler, D., Bruhn, D. & Optimus, JH Patientes estote prospectus in semel-weekly medicamentum pro diabete. Polonsky, Wh, Fisher, L., Hessler, D., Bruhn, D. & Optimus, JH Patientes estote prospectus in semel-weekly medicamentum pro diabete.Polonsky Wh, Fisher L., Hessler D., Brune D. et optimum JH a patientes estote in perspective in semel-weekly diabete medicamentum. Polonsky, Wh, Fisher, L., Hessler, D., Bruhn, D. & optimus, JH 患者对每周一次的糖尿病药物的看法. Polonsky, Wh, Fisher, L., Hessler, D., Bruhn, D. & optimus, JHPolonsky Wh, Fisher L., Hemerler D., Brune D. et optimum JH patientes sensus semel-weekly diabete medicamentum.Diabetic ADIPS. metabolism. XIII, 144-149 (MMXI).
Hashimoto, M., Takada, K., Kiso, Y. & Muranahi, S. synthesis Palmitisyl derivationes et insulin et in biologicis actiones. Hashimoto, M., Takada, K., Kiso, Y. & Muranahi, S. synthesis Palmitisyl derivationes et insulin et in biologicis actiones.Hashimoto M., Takada Kiso, Kiso Y. et Muranahi S. synthesis de Palmoi derivationes Insulin et biologicum actum. Hashimoto, M., Takada, K., Kiso, Muranahi Y. &, S. 胰岛素棕榈酰衍生物的合成及其生物活性. Hashimoto, M., Takada, K., Kiso, Y. & Muranahi, S. synthesis et biologicum actio de insulin palmoi derivationes.Hashimoto M., Takada C., Kiso Y. et Muranahi S. synthesis et biologicum actio de insulin palmitoyl derivationes.Medicinae alveus VI, 171-176 (MCMLXXXIX).
Kurtzhals, P. et al. Albumin binding ut pingue acid-acylated insulin: proprium Ligand, dapibus interactions et correlatione inter binding affinitatem et insulin actio tempore in vivo. Biochem. J. CCCXII, 725-731 (MCMXCV). Hoc opus est primum ad demonstrandum augmentum in dimidium-vita debitum ad binding of albumin ad peptides ex pingue acida.
Mejuch, T. & Waldmann, H. synthesis Lipidated proteins. Mejuch, T. & Waldmann, H. synthesis Lipidated proteins.Meyukh, T. et Waldmann, H. synthesis Lipidated proteins. Mejuch, T. & Waldmann, H. 脂化蛋白质的合成. Mejuch, T. & Waldmann, h.Meyukh, T. et Waldmann, H. synthesis Lipidated proteins.Bioconjugate. Chemical. XXVII, 1771-1783 (MMXVI).
Chen, B., sol, Y., Niu, J., Jarugumilli, GK & Wu, X. dapibus Lipidation in cell signum et morbos, munus, ordinacionem, et therapeutica occasiones. Chen, B., sol, Y., Niu, J., Jarugumilli, GK & Wu, X. dapibus Lipidation in cell signum et morbos, munus, ordinacionem, et therapeutica occasiones.Chen B., Sun Y., Niu J., Jarugumilli GK et Wu X. dapibus Lipidation in cell signum et morbus, munus, ordinacionem, et therapeuticam potentiale. Chen, B., sol, Y., Niu, J., Jarugumilli, GK & Wu, X. 细胞信号和疾病中的蛋白质脂化: 功能, 调节和治疗机会. Chen, B., sol, Y., Niu, J., Jarugumilli, GK & Wu, X. dapibus 脂化 in cell signum et morbo, munus, ordinacione et medicinales occasiones.Chen B., Sun Y., Niu J., Jarugumilli GK et Wu X. dapibus Lipidation in cell signum et morbus, munus, ordinacionem, et therapeuticam potentiale.Cytochemistry. Latina XXV, 817-831 (MMXVIII).
Richter, WF, Bhansali, SG & Morris, Me Mechanistic determinants of Biotharapeutics absorption his SC Administration. Richter, WF, Bhansali, SG & Morris, Me Mechanistic determinants of Biotharapeutics absorption his SC Administration.Richter, VF, Bhansali, SG et Morris, mihi machinationes determinare effusio de Biotherapeutica agentibus post telae administrationem. Richter, WF, Bhansali, SG & Morris, mihi SC 给药后生物治疗药物吸收的机制决定因素. Richter, WF, Bhansali, SG & Morris, mihi SC Richter, WF, Bhansali, SG & Morris, mihi SC механистические детернанты абсорбии препаратов после Введения. Richter, WF, Bhansali, SG & Boethius, mihi Certe Mechanistic determinantium de Biotherapeutic medicinae post administrationem.Aaps J. XIV, 559-570 (MMXII).
Gradel, AKJ et al. Factores afficiens telaing subcutaneous insulin effusio: effectus variabilitatem. J. diabete res. MMXVIII, (MCCV) CXXI ​​(MMXVIII).
Hildebrandt, P., Sejrsen, P., Nielsen, Sl, Betula, K. & Sestoft, L. diffusio et polymerization determinat insulin absorption ex telate in diabetic aegris. Hildebrandt, P., Sejrsen, P., Nielsen, Sl, Betula, K. & Sestoft, L. diffusio et polymerization determinat insulin absorption ex telate in diabetic aegris. Hildebrandt, P., Sejrsen, P., Nielsen, Sl, Betulis, K. & Sestoft, L. дифузана полимеризацялина из подкожной ткана из подкожной пациентов с диабетом. Hildebrandt, P., Sejrsen, P., Nielsen, Sl, Betula, K. & Sestoft, L. diffusio et polymerization determinare insulin effusio ex telae TEXTUS in diabetic aegris. Hildebrandt, P., Sejrsen, P., Nielsen, Sl, Betulis, K. & Sestoft, L. 扩散和聚合决定了糖尿病患者皮下组织对胰岛素的吸收. Hildebrandt, P., Sejrsen, P., Nielsen, Sl, Betula, K. & Sestoft, L. L. Hildebrandt, P., Sejrsen, P., Nielsen, Sl, Betulis, K. & Sestoft, L. диффуууяя и абгрегью инсулина подкожной тканью иу инь подкожной иу инсоуна подкожнь туалиннна подкожной пациентов с диабетом. Hildebrandt, P., Sejrsen, P., Nielsen, Sl, Betula, K. & Sestoft, L. Diffusio et aggregatio determinare subcutaneous insulin effusio in diabetic aegris.scanning. J. Klin. laboratorium. Obsido. XLV, 685-690 (MCMLXXXV).
Mosekilde, E., Jensen, KS, ligator, C., praymmnge, S. & Thorsteinsson, B. modeling effusio Kinetics de telae infusum solutum insulin. Mosekilde, E., Jensen, KS, ligator, C., praymmnge, S. & Thorsteinsson, B. modeling effusio Kinetics de telae infusum solutum insulin.Mosekildte E, Jensen Ks, Seneca S, PREMMMING S et ThORTEINsson B. Modeling Effusio Kinetics de telae solutum insulin. Mosochilde, E., Jensen, KS, ligator, C., praymmnge, S. Thorsteinsson, B. 模拟皮下注射可溶性胰岛素的吸收动力学. Mosochilde, E., Jensen, Ks, ligator, C., praymmnge, S. Thorsteinsson, B.Mosekildte E, Jensen Ks, Seneca S, PREMMMING S, et Thorstteinsson B. Modeling ad effusio Kinetics de subtercuttit, solutum insulin.J. Pharmacokinetics. Biopharmacy. XVII, 67-87 (MCMLXXXIX).
Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL iii Molecular mole modulat pharmacokinetics, biodistriberribribution Elasin, sicut polypeftide. Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL iii Molecular mole modulat pharmacokinetics, biodistriberribribution Elasin, sicut polypeftide. Kuna, M. Mahdi, F., Chade, AR & Bidwell, gl III размер молекулы модулирует и Отжениеделение и Отжениедение и Отжение в почкае биополимерного эластинододобного полипододобного постпти11дда для доставки леедстварственного средства. Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL iii Molecular mole modulat pharmacokinetics, biodistribion, et renales deposicionem de biodistin, sicut polypeptide ad medicamento partus. Kuna, M., Mahdi, F., Chade, AR & Bidwell, GI III 分子大小调节药物递送生物聚合物弹性蛋白样多肽的药代动力学, 生物分布和肾脏沉积. Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III moleculo 大小名行电影送送 biologicum polymerum elastica sample 多如乐的药代报学学, biologicum distribution 和鈥脏气度.Kuna, M. Mahdi, F., Chad, AR et Bidwell, GL iii. Pharmacokinetics, biodistriber et renales depositionem de Biopolymery Elastin, sicut polypeptides modulating magnitudinem moleculo.Scientia Report VIII, (VII) CMXXIII (MMXVIII).
Tullius Cicero, JM, Martin, NE & Modi, M. Pygylation: A Novel processus ad modificare pharmacokinetics. Tullius Cicero, JM, Martin, NE & Modi, M. Pygylation: A Novel processus ad modificare pharmacokinetics. Harris, JM, Martin, & Modi, M. Пегилирование: новый процесс модикики процрмакокикии. Tullius Cicero, JM, Martin, NE & Modi, M. Pygylation: A Novel processus ad modificare pharmacokinetics. Harris, JM, Martin, NE & Modi, M. 聚乙二醇化: 一种改变药代动力学的新方法. Harris, JM, Martin, Ne & Modi, M. 聚乙二感化: Novum modum mutantur medicina. Harris, JM, Martin, NE & Modi, M. Пегилирование: новый подхокинененению подакакокики арметики. Tullius Cicero, JM, Martin, NE & Modi, M. Pygylation: Novum Aditus mutantur pharmacokinetics.C.. Pharmacokinetics. XL, 539-551 (MMI).
Elmerer, M. et al. Mensurement of interstitial albumin in humana Osseus musculus et adipose TEXTUS in aperto fluxus microperfusion. Ita. J. Physiologia. endocrinarum. metabolism. CCLXXVIII, E352, E356 (MM).
Nelson, J. et al. Diu dimidium-vita et albumin in hominibus requirit in integrum c-terminus. communicare. Biology. III, CLXXXI (MMXX).
Chowdhury, K. et al. Et FC receptor (FCRN) ad IGG consociata cum Maior histocpatibility complexu ligat albumin et longam suam lifespan. J. EXP. medicamentum. CXCVII, 315-322 (MMIII).
Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Equitum Solis, ES exocytosis de IGG ut mediante per receptor, fcrn, an analysis in uno-Molecule campester. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Equitum Solis, ES exocytosis de IGG ut mediante per receptor, fcrn, an analysis in uno-Molecule campester. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Equitum Solis, ES экзоцитоз IGG, опосредованнннй es опосредой рецеклы уровне, одной уровне одной рецеклы уровне: Ан уровнне одной одной уровне одной уровне одной уровне одной рецеклы уровне одной Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Equitum Solis, es Fcrn receptor-Mediated IGG exocytosis: Una-Molecule Analysis. Ober, RJ, Martinez, C., Lai, X, Zhou, J. & Equites, es 受体介导的 IGG 胞吐作用, Fcrn: 单分子水平的分析. Ober, RJ, Martinez, C., Lai, X, Zhou, J. & Equites, es Ober, RJ, Martinez, C., Lai, X, Zhou, J. & Equitum Solis, экзоцитоз IGG, опосредованнннннй рееецекулы уровне одной Ober, RJ, Martinez, C., Lai, X, Zhou, J. & Equitum Solis, es receptor-mediated IGG exocytosis, Fcrn: una moleculae-gradu analysis.processus. National Academy of Science. In scientia. US CI, (XI) LXXVI (MMIV).
Ipse, XM & Carter, DC Atomic structuram et Chemiae Humanum Serum albumin. Ipse, XM & Carter, DC Atomic structuram et Chemiae Humanum Serum albumin.De, XM et Carter, DC Atomicus structuram et Chemiae Humanum Serum Albumin. Ipse, XM & Carter, DC 人血清白蛋白的原子结构和化学. Ipse, XM & Carter, DC.De, XM et Carter, DC Atomicus structuram et Chemiae Humanum Serum Albumin.Natura CCCLVIII, 209-215 (MCMXCII).
Curry, S., Mandelkow, H., Bricks, P. & Franci, N. Crystal structuram Humanum Serum albumin complexed cum pingue acidum reveals est asymmetric distribution of binding sites. Curry, S., Mandelkow, H., Bricks, P. & Franci, N. Crystal structuram Humanum Serum albumin complexed cum pingue acidum reveals est asymmetric distribution of binding sites.Curry S., Mandelkow H., Bricks P. et Francorum N. Crystal structuram humanae Serum albumin in complexu cum pingue acidum ostendit an asymmetric distributionem distributionem sites. Curry, S., Mandelkow, H., Bricks, P. & Franci, N. 与脂肪酸复合的人血清白蛋白的晶体结构揭示了结合位点的不对称分布. Curry, S., Mandelkow, H., Bricks, P. & Franci, N. Crystal structuram humanae Serum albus interdum universa cum pingue acidis reveals est asymmetric distribution et adipiscing sites.Curry S., Mandelkow H., laterem P. et Francorum N. Crystal structuram humanae Serum albumin in complexu cum pingue acidis ostendit an asymmetric distribution et adipem sites.Nat. structuram. V biology, 827-835 (MCMXCVIII). Hoc charta munera structural ex binding of pingue acida ad serum albumin.
Irby, D., du, C. & Li, F. Lipid-medicamento Conjugate enim enhancing medicamento partus. Irby, D., du, C. & Li, F. Lipid-medicamento Conjugate enim enhancing medicamento partus.Irby, D., du, K. et Li, F. Lipid-medicamento Conjugat ad amplificare medicamento partus. Irby, D., du, C. & Li, F. Lipid-medicamento Conjugate ad augendae medicamento partum. Irby, D., du, C. & Li, F. Lipid-medicamento Conjugate ad augendae medicamento partum.Irby, D., du, K. et Li, F. Lipid-medicamento Conjugate ad amplificare medicamento partus.Biochemistry XIV, 1325-1338 (MMXVII).
Torchilin VP eget in agro Liposomes ut medicamento carriers. Nationalibus ostium de medicamento pastor. IV, 145-160 (MMV).
Bhat, M., Jatyan, R., Mittal, A., Mahato, Ri & Chitkara, D. occasiones et challenges et pingue acidum coniugated. Bhat, M., Jatyan, R., Mittal, A., Mahato, Ri & Chitkara, D. occasiones et challenges et pingue acidum coniugated.Bhat, M., Jatyan, R., Mittal, A., Mahato, Ri et Chitkara, D. occasiones et challenges et pingue acidum coniugated. Bhat, M., Jatyan, R., Mittal, A., Mahato, Ri & Chitkara, D. 脂肪酸共轭疗法的机遇和挑战. Bhat, M., Jatyan, R., Mittal, A., Mahato, Ri & Chitkara, D. ADIPATUS Acidum 共续电影的机遇和 provocatione.Bhat M., Jatyan R., Mittal A., Mahate Ri et Chitkara D. possibilities et challenges de pingue acidum coniugation Lorem.Chemical. Physicis lipids CCXXXVI, (MV) LIII (MMXXI).
Smith, R. & Tanford, C. hydrophobicity longo torquem n-alkboxylic acida, ut metiri distribution inter Heptane et aqueum solutions. Smith, R. & Tanford, C. hydrophobicity longo torquem n-alkboxylic acida, ut metiri distribution inter Heptane et aqueum solutions.Smith, R. et Tanford, K. Hydrophobicity longa-torquem n-alkylcarboxylic acida metiri per distribution inter Heptane et aqueum solutions. Smith, R. & Tanford, C. 长链正烷基羧酸的疏水性, 通过它们在庚烷和水溶液之间的分布来测量. Smith, R. & Tanford, C. et hydrophobicity 长链正 alkylcarboxylate, metiri per distribution inter hydrogenii peroxide et aqueum solutio.Smith, R. et Tanford, K. Hydrophobicity longa-torquem n-alkylcarboxylic acida metiri per distribution inter Heptane et aqueum solutions.processus. National Academy of Sciences. Science US LXX, CCLXXXIX (MCMLXXIII).
Liu, J. et al. Semel-weekly inventionis in semaglutide Analog Glucagon, sicut peptide-I (Glp-I). J. Medicine. Chemical. LVIII, 7370-7380 (MMXV). Hoc opus demonstrat primum facultatem utendi semel in septimana pingue acidum derivatization modi.
Østergaard, S. et al. Effectus humani pyy3-36 dibasic pingue acid acylation in mini-sus y2 receptor actio et dimidium-vita. In scientia. Report XI, (XXI) CLXXIX (MMXXI). Hoc articulum monstrat momenti pingue acid positus, linker et backbone stabilitatem in progressionem diu dimidium-vita pyy analogs.
Ensenat, Vaser, R. et al. Penetratio Myristo Goymed Peptides per cellulam membranam fuit directe observata per confocal fluorescence microscopy. Iubmb vitae LIV, 33-36 (MMII).
Nelson, AR, Borland, L., Allbritton, NL & Sims, CE Myristoyl, secundum onerariis ex peptides in animam viventem cellulis. Nelson, AR, Borland, L., Allbritton, NL & Sims, CE Myristoyl, secundum onerariis ex peptides in animam viventem cellulis.Nelson AR, Borland L, Allbritton NL. Et sims se peptide onerariis in animam viventem cellulis fundatur in Myristoyl. Cicero, Ar, Borland, L., Allbritton, NL & Sims, CE 基于肉豆蔻酰的肽转运到活细胞中. Nelson, AR, Borland, L., Allbritton, NL & Sims, CE.Nelson, AR, Borlandi, L., Albritton, NL. Et Sims, KE onerariis Myristoyl, secundum peptides in animam viventem cellulis.Biochemistry XLVI, 14771-14781 (MMVII).
Kabanov AV, Levashov, AV & Alakhov, vy lipid modificatio et proteins et membrana onerariam. Kabanov AV, Levashov, AV & Alakhov, vy lipid modificatio et proteins et membrana onerariam.Kabanov AV, Levashov av, alakhov v.yu. Lipidorum modificatio proteins et membrana onerariam. Kabanov AV, Levashov, AV & Alakhov, vy 蛋白质的脂质修饰及其膜转运. Kabanov AV, Levashov, AV & Alakhov, VyKabanov av, Levashov Av, Alakhov, lipidorum modificatio Vy proteins et membrana onerariam.Dapibus ipsum. Wartl. III, 39-42 (MCMLXXXIX).
Gao, X., Mazière, AD, Barba, R., Klumperman, J. & Hannoush, RN pingue acylation enhances cellularum internalization et cytosolic distribution of a Cystineo-nodum peptide. Gao, X., Mazière, AD, Barba, R., Klumperman, J. & Hannoush, RN pingue acylation enhances cellularum internalization et cytosolic distribution of a Cystineo-nodum peptide.Gao, X., Mazier, AD, Byrd, R., Klumperman, J. et Hannoosh, RN pingue acid acylation enhances cellular internum et cystosolic distribution of peptide cum cystineo et cystosolic distribution of peptide cum cystineo ansa. Gao, X., Mazière, AD, Barba, R., Klumperman, J. & Hannoush, RN 脂肪酰化增强了胱氨酸结肽的细胞内化和胞质分布. Gao, X., Mazière, AD, Barba, R., Klumperman, J. & Hannoush, RN.Gao, X., Mazier, AD, Byrd, R., Klumperman, J. et Hannoosh, RN pingue acylation enhances cellular internalization et cytoplasmic distributio Cystino Peptides.Iscience XXIV, (CIII) CCXX (MMXI).
Baker, em et al. Media-vita, longa mutatio de Yy3-36 peptide in directum receptor-mediata internalization. Moore. medicamentum. XVI, 3665-3677 (MMXIX).
Mäde, V., Bellmann-Skercert, K., Kaiser, A., Meiler, J. & Beck-Beckinger, AG situm et longitudinem ex pingue acida fortiter afficiunt receptor selectivity. Mäde, V., Bellmann-Skercert, K., Kaiser, A., Meiler, J. & Beck-Beckinger, AG situm et longitudinem ex pingue acida fortiter afficiunt receptor selectivity.Factus, W., Bellmann, Skercert, K., Kaiser, A., Mailer, J. et Beck-Becker, AG et longitudinem pingue acidis fortiter in selectivity exemplar humanae pancrae fortiter receptores. Mäde, V., Bellmann-Skercert, K., Kaiser, A., Mee ER, J. & Beck-Becking, AG 脂肪酸的位置和长度强烈影响人胰腺多肽类似物的受体选择性模式. Mäde, V., Bellmann-Skercert, K., Kaiser, A., Mee ER, J. & Beck-Becker, AGFecit, W., Bellmann, Skercert, K., Kaiser, A., Mailer, J. et Beck-Becker, AG et longitudinem pingue acida analog selectivity humanae pancreatas analogue in propria.Himsedchem IX, 2463-2474 (MMXIV).
Aleksopoulou, F. et al. Lipidorum metabolite prrp31 diu agens dual GP01 et NPFF2 receptor agonist cum potens pondus damnum effectus. In scientia. Report XII, MDCXCVI (MMXII). Hoc methodological studium volutpat differentias inter Mono- et diacidra latus vincula.
Poulsen, K. et al. Rationalis progressionem stabilis agonists in y2 receptor peptide pyy3-36. medicamentum. PRAECLUSIO TANK. XXXVIII, 1369-1385 (MMXXI).
FRIBEOES, K. ​​et al. Identificatio et propria in vitro et in vivo analoga of longa agens et selectivam Melanocortin IV receptor (MC4-r) alpha-melanococyte-stimulating hormone (Alpha, MSlanocyte,). J. Medicine. Chemical. LV, 1969-1977 (MMXII).
Ramirez, Andersen, HS et al. Long-agens Humanum incrementum hormone analoga tenetur ad non-covalent albumin. Bioconjugate. Chemical. XXIX, 3129-3143 (MMXVIII).
Madsen, K. et al. Structure-actio necessitudinem et elongatio diu agens Glucagon-sicut peptide-I derivationes: De pingue acidum longitudinem momentum, et volumen. J. Medicine. Chemical. L, 6126-6132 (MMVII).
Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Geminus-Acylated Glp-I derivationes. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Geminus-Acylated Glp-I derivationes. Wieczorek, B., Spetzler, JC, Kruse, T., Lindothy, L. & Kofoed, J. дважжжые ацилированные производы GlP-I. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. duplicibus acylated derivationes GLP, I. Wieczorek, B., Spetzler, JC, Kruse, T., Lindothy, L. & Kofoed, J. 双酰化 Glp I 衍生物. Wieczorek, B., Spetzler, JC, Kruse, T., Lindothy, L. & Kofoed, J. 双酰化 Glp I 衍生物. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. диацилилированные производые GLP-I. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth L. & Kofoed, J. Diacylated derivationes GLP, I.Wo1012 US Patent / (CXL) CXVII (MMXII).
Young, p.-yu. Exspecta. Potent, diu agens GLP I analogs disposito transdermal partus secundum microstructure. processus. National Academy of Science. In scientia. US CXIII, 4140-4145 (MMXVI).
Regium, Je, Konradsen, G., Eskerod, O., Wulff, BS & Hansen, BS Investigatione de Salutis, Tolerability, Pharmacokinetics et Longum agens α MSOD et multiplex in sanus AUCTARIUM et obesus Subjects. Regium, Je, Konradsen, G., Eskerod, O., Wulff, BS & Hansen, BS Investigatione de Salutis, Tolerability, Pharmacokinetics et Longum agens α MSOD et multiplex in sanus AUCTARIUM et obesus Subjects.Regium, Je, Konradsen, G., Eskerod, O., Lupus, BS et Hansen, BS Safety, Tolerability, Pharmacokinetics et pharmacodynamics studium unam et multa doses longa agens α-MSG Analog in Healthus AUCTARIUM et obese subiecta.版税, Je, Konradsen, G., Eskerod, O., Wulff, BS & Hansen, BS 单剂量和多剂量长效 α-msh 类似物在健康超重和肥胖患者中的安全性, 耐受性, 药代动力学和药效学研究科目.版税, Je, Konradsen, G., Eskerod, O., Wulff, BS & Hansen, BS una dosis et multi dosage diu effectum α-msh 全健康超重和肥胖可以中可以可以而受性, 药代报学学和药效学研究科目.Regium, Je, Konradsen, G., Eskerod, O., Lupus, BS et Hansen, BS Safety, Tolerability, Pharmacokinetics de una et multiplex doses longa agens alpha, msg analoga in sanus overweight et obesus MSG analoga in sanus AUCTARIUM et obesus MSG analoga in sanus AUCTARIUM et obesus MSG analoga in sanus per overweight et obese subiectis. Kinetics et pharmacodynamics.J. Clin. Pharmacodynamics. LIV, 394-404 (MMXIV).
Lau, J., F., Kruse, T., Linderoth, L. & Thøgersen, H. Novel Glucagon analoga. Lau, J., F., Kruse, T., Linderoth, L. & Thøgersen, H. Novel Glucagon analoga.Lau, J., F., Kruse, T., Lindoth, L. et Togersen, H. New Glucagon analoga. Lau, J., F., Kruse, T., Lindoth, L. & Thøgersen, H. 新型胰高血糖素类似物. Lau, J., F., Kruse, T., Lindoth, L. & Thøgersen, H.Lau, J., F., Cruz, T., Lindoth, L. et Togersen, H. New Glucagon analoga.US Patent Wo1011 / (CXVII) CDXVI A1 (MMXI).
Equitum, BP et al. Lipidationis Peptides stabilizes structurae augendae biologicum munus. Moore. metabolism. II, 468-479 (MMXIII). Hoc opus monstrat ad partes pingue acidum latus vincula in determinandum structural stabilitatem et binds peptide medicamento receptores.
Koskun T. et al. Ly3298176, a nove dual gip et glp-I receptor agonist ad curatio type II diabete: ex inventionis ad orci probationem conceptu. Moore. metabolism. XVIII, 3-14 (MMXVIII). Hoc charta presents consilio primi pingue acid-derived glp-I / GIP co-Agonist ad semel-weekly administratione in inhaero.
Kjeldsen, TB et al. Molecular Engineering de icodec insulin, primum semel, weekly acylated insulin Analog in hominibus. J. Medicine. Chemical. LXIV, 8942-8950 (MMXXI). Hoc charta presentes primi progressionem pingue acid derived insulin ad semel weekly administrationem.
Van Witteetisin, SB et al. Neoglycolipids enim longa-agens peptides: auto-coetuin analogs of glucagon, sicut peptide I cum albumin-binding proprietatibus et excelsum in vivo potentia. Moore. medicamentum. XIV, 193-205 (MMXVII).
Zorzi, A., middendorp, SJ, Wilbs, J., Deyle, K. & Heinis, C. ACIYLATUS HeptaPeptide Longin cum Altus affinitate et Application ut Tag Long-agens Peptides. Zorzi, A., middendorp, SJ, Wilbs, J., Deyle, K. & Heinis, C. ACIYLATUS HeptaPeptide Longin cum Altus affinitate et Application ut Tag Long-agens Peptides.Zorzi, A., Middendorp, SJ, Wilbs, J., Dale, K. et Haynes, S. ACIYTUS Heptapepide Albumin cum alta affinitate, et usum sicut Label diu agens peptide praebet. Zorzi, A., middendorp, SJ, Wilbs, J., Deyle, K. & Heinis, C. 酰化七肽以高亲和力结合白蛋白, 并作为标签提供长效肽. Zorzi, A., Middendorp, SJ, Wilbs, J., Deyle, K. & Heinis, C. 鎄化七 peptide 以高亲和力设计白白约筒, 使用于设计手机长整线等.Zorzi, A., middendorp, SJ, Wilbs, J., Dale, K. et Haynes, S. ACIYTUS HeptaPeptides Longin cum High affinitate et serve sicut Label Longin cum Peptide partus.Nat. Communicate VIII, (XVI) XCII (MMXVII).